• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Respiratory Syncytial Virus: A Year of Infant Protection Breakthroughs

Commentary
Article

The world's first maternal vaccine against RSV in neonates and infants was approved in August. This brief slide show highlights the clinical trials that made history.

A vaccine against respiratory syncytial virus for newborns and young infants has been elusive since a clinical trial in the mid-1960s that resulted in nearly all the study participants being hospitalized with the infection and the death of 2 infants.

Recent Videos
Infectious disease specialist talks about COVID-19 vaccine development
COVID 19 impact on healthcare provider mental health
Physician mental health expert discusses impact of COVID-19 on health care workers
Related Content
FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine / Image credit: ©Kateryna_Kon/AdobeStock

FDA Lifts Clinical Hold on Novavax’s COVID-19-Influenza Combination Vaccine

Sydney Jennings
November 12th 2024
Article

The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Sydney Jennings
November 11th 2024
Article

Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Primary Viewpoints Episode 11: AAFP President-elect Discusses Greatest Concerns about Upcoming Flu Season

Sydney Jennings
September 13th 2021
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with incoming AAFP president Sterling Ransone, MD.

The Legacy of Vaccine Hesitancy: From COVID-19 to Flu

The Legacy of Vaccine Hesitancy: From COVID-19 to Flu

October 22nd 2024
Article

Vaccine hesitancy became a public health threat during the COVID-19 pandemic that lingers now and has affected uptake of other essential immunizations.

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults / Image credit: ©Tobias Arhelger/AdobeStock

Pfizer-BioNTech COVID-19 Vaccine May Reduce Risk of Long COVID in Older Adults

Sydney Jennings
October 21st 2024
Article

IDWeek 2024: Older adults vaccinated with BNT162b2 (Comirnaty) had approximately half the odds of developing long COVID vs unvaccinated adults, according to new data.

© 2024 MJH Life Sciences

All rights reserved.